Peregrine’s Subsidiary Begins First Commercial Stage Drug Manufacturing Project
|
|
Avid Bioservices Is Manufacturing the Active Ingredients for Hylenex(TM), Now Approved for Marketing by the FDA - TUSTIN, Calif., Dec. 6 /PRNewswire-FirstCall/ — Avid Bioservices, Inc., the wholly owned manufacturing subsidiary of Peregrine Pharmaceuticals, Inc. , became a commercial stage manufacturing organization as FDA approval was announced for commercial distribution of a recombinant human enzyme Avid is manufacturing for Halozyme Therapeutics. Avid produces the active pharmaceutical ingredients (API) for the drug Hylenex(TM). The API produced by Avid will be Source : accessmylibrary.com |